Patents by Inventor Anjurn ZAFAR

Anjurn ZAFAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stem cell modulation II
    Patent number: 10736892
    Abstract: Disclosed are methods and compositions for modulating cancer stem cells. More particularly, the present invention discloses the use of protein kinase C theta inhibitors (PKC-?) for inhibiting the growth of PKC-?-overexpressing cells including cancer stem cells, for enhancing the biological effects of chemotherapeutic drugs or irradiation on cancer cells, for treating cancer, including metastatic cancer and/or for preventing cancer recurrence.
    Type: Grant
    Filed: November 12, 2018
    Date of Patent: August 11, 2020
    Assignee: EpiAxis Therapeutics Pty Ltd.
    Inventors: Sudha Rao, Anjurn Zafar
  • Stem Cell Modulation II
    Publication number: 20190192509
    Abstract: Disclosed are methods and compositions for modulating cancer stem cells. More particularly, the present invention discloses the use of protein kinase C theta inhibitors (PKC-?) for inhibiting the growth of PKC-?-overexpressing cells including cancer stem cells, for enhancing the biological effects of chemotherapeutic drugs or irradiation on cancer cells, for treating cancer, including metastatic cancer and/or for preventing cancer recurrence.
    Type: Application
    Filed: November 12, 2018
    Publication date: June 27, 2019
    Inventors: Sudha RAO, Anjurn ZAFAR